Header Logo

Connection

J. Donahue to Animals

Back to Details
This is a "connection" page, showing publications J. Donahue has written about Animals.
J. Donahue
Connection Strength
0.977
Animals
  1. Mo W, Donahue JK. Gene therapy for atrial fibrillation. J Mol Cell Cardiol. 2024 Nov; 196:84-93.
    View in: PubMed
    Score: 0.066
  2. Benson JM, Wang G, Hutt JA, Wu G, Kaminsky SM, Cram S, Barur R, Donahue JK. Preclinical safety and biodistribution assessment of Ad-KCNH2-G628S administered via atrial painting in New Zealand white rabbits. Basic Clin Pharmacol Toxicol. 2023 Aug; 133(2):179-193.
    View in: PubMed
    Score: 0.060
  3. Callans DJ, Donahue JK. Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia. JACC Clin Electrophysiol. 2022 06; 8(6):713-718.
    View in: PubMed
    Score: 0.056
  4. Kelemen K, Greener ID, Wan X, Parajuli S, Donahue JK. Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar. Nat Commun. 2022 02 11; 13(1):830.
    View in: PubMed
    Score: 0.055
  5. Mo W, Donahue JK. Atrial Gene Painting in Large Animal Model of Atrial Fibrillation. Methods Mol Biol. 2022; 2573:205-216.
    View in: PubMed
    Score: 0.055
  6. Liu Z, Finet JE, Wolfram JA, Anderson ME, Ai X, Donahue JK. Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure. Heart Rhythm. 2019 07; 16(7):1080-1088.
    View in: PubMed
    Score: 0.045
  7. Donahue JK. Current state of the art for cardiac arrhythmia gene therapy. Pharmacol Ther. 2017 Aug; 176:60-65.
    View in: PubMed
    Score: 0.040
  8. Liu Z, Hutt JA, Rajeshkumar B, Azuma Y, Duan KL, Donahue JK. Preclinical efficacy and safety of KCNH2-G628S gene therapy for postoperative atrial fibrillation. J Thorac Cardiovasc Surg. 2017 11; 154(5):1644-1651.e8.
    View in: PubMed
    Score: 0.040
  9. Donahue JK. Gene Therapy for Post-infarction Ventricular Tachycardia. Methods Mol Biol. 2017; 1521:307-321.
    View in: PubMed
    Score: 0.039
  10. Donahue JK. Biological Therapies for Atrial Fibrillation: Ready for Prime Time? J Cardiovasc Pharmacol. 2016 Jan; 67(1):19-25.
    View in: PubMed
    Score: 0.036
  11. Nassal MM, Werdich AA, Wan X, Hoshi M, Desch?nes I, Rosenbaum DS, Donahue JK. Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress. J Cardiovasc Electrophysiol. 2016 Jan; 27(1):110-9.
    View in: PubMed
    Score: 0.036
  12. Wolfram JA, Donahue JK. Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013 Aug 20; 2(4):e000119.
    View in: PubMed
    Score: 0.031
  13. Greener ID, Sasano T, Wan X, Igarashi T, Strom M, Rosenbaum DS, Donahue JK. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. J Am Coll Cardiol. 2012 Sep 18; 60(12):1103-10.
    View in: PubMed
    Score: 0.029
  14. Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, Rosenbaum DS, Donahue JK. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation. 2012 Jan 17; 125(2):216-25.
    View in: PubMed
    Score: 0.027
  15. Amit G, Kikuchi K, Greener ID, Yang L, Novack V, Donahue JK. Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation. 2010 Jun 01; 121(21):2263-70.
    View in: PubMed
    Score: 0.024
  16. Sasano T, Kelemen K, Greener ID, Donahue JK. Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy. Heart Rhythm. 2009 Aug; 6(8 Suppl):S91-7.
    View in: PubMed
    Score: 0.023
  17. Finet JE, Rosenbaum DS, Donahue JK. Information learned from animal models of atrial fibrillation. Cardiol Clin. 2009 Feb; 27(1):45-54, viii.
    View in: PubMed
    Score: 0.022
  18. Amit G, Qin H, Donahue JK. Biological therapies for atrial fibrillation. J Cardiovasc Pharmacol. 2008 Sep; 52(3):222-7.
    View in: PubMed
    Score: 0.022
  19. Donahue JK, Sasano T, Kelemen K. Gene therapy approaches to ventricular tachyarrhythmias. J Electrocardiol. 2007 Nov-Dec; 40(6 Suppl):S187-91.
    View in: PubMed
    Score: 0.020
  20. Sasano T, Kikuchi K, McDonald AD, Lai S, Donahue JK. Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol. 2007 May; 42(5):954-61.
    View in: PubMed
    Score: 0.020
  21. Sasano T, McDonald AD, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med. 2006 Nov; 12(11):1256-8.
    View in: PubMed
    Score: 0.019
  22. Donahue JK. Gender and the heart. Heart Rhythm. 2006 Jul; 3(7):840-1.
    View in: PubMed
    Score: 0.018
  23. Donahue JK, Kikuchi K, Sasano T. Gene therapy for cardiac arrhythmias. Trends Cardiovasc Med. 2005 Aug; 15(6):219-24.
    View in: PubMed
    Score: 0.018
  24. Donahue JK, Bauer A, Kikuchi K, Sasano T. Modification of cellular communication by gene transfer. Ann N Y Acad Sci. 2005 Jun; 1047:157-65.
    View in: PubMed
    Score: 0.017
  25. Kikuchi K, McDonald AD, Sasano T, Donahue JK. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation. 2005 Jan 25; 111(3):264-70.
    View in: PubMed
    Score: 0.017
  26. Bauer A, McDonald AD, Nasir K, Peller L, Rade JJ, Miller JM, Heldman AW, Donahue JK. Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation. Circulation. 2004 Nov 09; 110(19):3115-20.
    View in: PubMed
    Score: 0.017
  27. Bauer A, McDonald AD, Donahue JK. Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure. Cardiovasc Res. 2004 Mar 01; 61(4):764-70.
    View in: PubMed
    Score: 0.016
  28. Lehnart SE, Donahue JK. Coronary perfusion cocktails for in vivo gene transfer. Methods Mol Biol. 2003; 219:213-8.
    View in: PubMed
    Score: 0.015
  29. Neyroud N, Nuss HB, Leppo MK, Marb?n E, Donahue JK. Gene delivery to cardiac muscle. Methods Enzymol. 2002; 346:323-34.
    View in: PubMed
    Score: 0.014
  30. Nagata K, Marb?n E, Lawrence JH, Donahue JK. Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J Mol Cell Cardiol. 2001 Mar; 33(3):575-80.
    View in: PubMed
    Score: 0.013
  31. Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ, Eschenhagen T, Marb?n E. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med. 2000 Dec; 6(12):1395-8.
    View in: PubMed
    Score: 0.013
  32. Donahue JK, Kikkawa K, Thomas AD, Marban E, Lawrence JH. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther. 1998 May; 5(5):630-4.
    View in: PubMed
    Score: 0.011
  33. Donahue JK, Kikkawa K, Johns DC, Marban E, Lawrence JH. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci U S A. 1997 Apr 29; 94(9):4664-8.
    View in: PubMed
    Score: 0.010
  34. Panda NC, Zuckerman ST, Mesubi OO, Rosenbaum DS, Penn MS, Donahue JK, Alsberg E, Laurita KR. Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel. J Interv Card Electrophysiol. 2014 Nov; 41(2):117-27.
    View in: PubMed
    Score: 0.008
  35. Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, Ogawa M, Chen PS, Efimov I, Dobrev D, Mohler PJ, Hund TJ, Anderson ME. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest. 2011 Aug; 121(8):3277-88.
    View in: PubMed
    Score: 0.007
  36. Ashikaga H, Sasano T, Dong J, Zviman MM, Evers R, Hopenfeld B, Castro V, Helm RH, Dickfeld T, Nazarian S, Donahue JK, Berger RD, Calkins H, Abraham MR, Marb?n E, Lardo AC, McVeigh ER, Halperin HR. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res. 2007 Oct 26; 101(9):939-47.
    View in: PubMed
    Score: 0.005
  37. Kapur NK, Deming CB, Kapur S, Bian C, Champion HC, Donahue JK, Kass DA, Rade JJ. Hemodynamic modulation of endocardial thromboresistance. Circulation. 2007 Jan 02; 115(1):67-75.
    View in: PubMed
    Score: 0.005
  38. Murata M, Cingolani E, McDonald AD, Donahue JK, Marb?n E. Creation of a genetic calcium channel blocker by targeted gem gene transfer in the heart. Circ Res. 2004 Aug 20; 95(4):398-405.
    View in: PubMed
    Score: 0.004
  39. Bauer A, Donahue JK, Voss F, Becker R, Kraft P, Senges JC, Kelemen K, Katus HA, Schoels W. Pro- and antiarrhythmic effects of fast cardiac pacing in a canine model of acquired long QT syndrome. Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr; 369(4):447-54.
    View in: PubMed
    Score: 0.004
  40. Janssen PM, Schillinger W, Donahue JK, Zeitz O, Emami S, Lehnart SE, Weil J, Eschenhagen T, Hasenfuss G, Prestle J. Intracellular beta-blockade: overexpression of Galpha(i2) depresses the beta-adrenergic response in intact myocardium. Cardiovasc Res. 2002 Aug 01; 55(2):300-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.